Primo Brands is a strong buy: integration is stabilizing, $300M synergies are on track, and an 8.2x EBITDA discount implies ...
In a remarkable pivot, Athira Pharma is shifting its primary focus from Alzheimer’s to oncology following a multi-year period marked by clinical failures and leadership turnover. The Bothell, ...
Cybin is shedding its old identity, evolving into Helus Pharma as part of changes that will see its shares move to a different stock exchange. The Toronto-based biotech plans to stop trading on NYSE ...
Pharma marketers enter 2026 asking where DTC fits in the DTP era. That question, which few foresaw 12 months ago, reflects the fast rise of direct-to-patient (DTP) programs. In the last few months ...
Looking back on 2025, a lot happened in the world of healthcare. This year was largely defined by the arrival of the second Trump administration, armed with tariff threats, unorthodox views about ...
Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...
In this article, we will be taking a look at the 9 Most Undervalued Pharma Stocks to Buy Right Now. The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable ...
Dragon Quest VII Reimagined is set to release February 3, 2026 if you buy the more expensive editions, or February 5 for the standard edition. It’s coming to PS5, Switch, Switch 2, Xbox Series X|S, ...
The Dragon Age is an era in the history of Thedas, specifically one where nobody on the continent could seem to catch a break. Each mainline game in Bioware’s fantasy RPG series introduces a new ...
LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...
WASHINGTON, DC – The U.S. Department of Justice has charged Indian chemical manufacturer Vasudha Pharma Chem Limited (VPC) and three of its executives for allegedly importing precursor chemicals used ...
President Donald Trump announced Friday his administration has reached new agreements with some of the world’s largest drug manufacturers aimed at lowering prescription drug costs for Americans.